Drugs / TDV Liquid Formulation 1
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| Phase 2 | NCT02193087 Comparator | Aug 2014 → May 2015 | dengue disease | Takeda | Completed | Missed primary |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | TDV Liquid Formulation 1 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02193087 ↗ |
| Route | Subcutaneous | “TDV Liquid Formulation 1 for subcutaneous injection” NCT02193087 ↗ |